Your session is about to expire
← Back to Search
Stem Cell Therapy
Mesenchymal stem cells for Crohn's Disease
Phase 1
Waitlist Available
Led By Amy Lightner, MD
Research Sponsored by Amy Lightner
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up month 12
Awards & highlights
Study Summary
This trial will test if injecting stem cells into fistulas can heal them. 10 patients aged 13-17 will be treated at baseline and again 3 months later if needed.
Eligible Conditions
- Crohn's Disease Perianal Fistula
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ month 12
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~month 12
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Treatment related adverse events
Secondary outcome measures
Complete clinical healing
Lack of response
Partial clinical healing
+1 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Mesenchymal stem cellsExperimental Treatment1 Intervention
allogeneic bone marrow derived mesenchymal stem cells
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Mesenchymal stem cells
2020
Completed Phase 2
~150
Find a Location
Who is running the clinical trial?
Amy LightnerLead Sponsor
4 Previous Clinical Trials
140 Total Patients Enrolled
Amy Lightner, MD2.33 ReviewsPrincipal Investigator - The Cleveland Clinic
The Cleveland Clinic
18 Previous Clinical Trials
1,614 Total Patients Enrolled
1Patient Review
I had a very negative experience with Dr. Lightener. She caused me a great deal of harm and pain. I would not recommend her to anyone.
Share this study with friends
Copy Link
Messenger